DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Telli ML, Hellyer J, Audeh W. et al.
Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer.

Breast Cancer Res Treat 2018;
168: 625-630

Download Bibliographical Data

Search in:
Access:
Access: